#193 - AMA #31: Heart rate variability (HRV), alcohol, sleep, and more

#193 - AMA #31: Heart rate variability (HRV), alcohol, sleep, and more

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Episode Description:

In this "Ask Me Anything" (AMA) episode, Peter and Bob first answer a variety of questions related to heart rate variability (HRV): what it means, why it matters, and how to measure, interpret, and potentially elevate it. Next, they dive deep into the topic of alcohol, beginning with a discussion on the negative impact that it can have on sleep. They then break down the confusing body of literature suggesting potential health benefits to moderate levels of drinking compared to complete abstinence and point out the limitations of these studies. Finally, they conclude by analyzing data on the impact of moderate and heavy drinking on the liver and on risk for Alzheimer's disease and dementia.

Please note: this AMA is audio only. If you're not a subscriber and listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or on our website at the AMA #31 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

  • What is heart rate variability (HRV), and why do we measure it? [2:10];
  • The association between low HRV and mortality risk [10:00];
  • What high and low HRV means and why athletes strive for a high HRV [15:30];
  • Factors that can raise or lower HRV [18:00];
  • How and when to measure HRV, and the best wearables [19:15];
  • Interpreting your personal HRV number and why there's so much individual variation [23:15];
  • How Peter's morning HRV reading impacts his decision to train [28:30];
  • Alcohol's impact on sleep [31:30];
  • Metrics to track the impact of alcohol on your sleep [34:00];
  • Alcohol's impact on the need to urinate during the night [39:00];
  • Alcoholic fatty liver disease (AFLD) [41:30];
  • Individual differences in the way people metabolize and react to alcohol consumption [44:15];
  • Analysis of epidemiology studies suggesting moderate alcohol consumption lowers mortality risk [52:00];
  • Alcohol consumption and Alzheimer's disease [1:05:15];
  • Heavy alcohol consumption and risk of dementia [1:08:30];
  • Chronic effects of alcohol on the liver [1:17:45];
  • The relationship between alcohol, sleep, and automotive deaths [1:20:45]; and
  • More.

Sign Up to Receive Peter's Weekly Newsletter

Connect With Peter on Twitter, Instagram, Facebook & YouTube

Avsnitt(435)

Optimizing life for maximum fulfillment | Bill Perkins (#237 rebroadcast)

Optimizing life for maximum fulfillment | Bill Perkins (#237 rebroadcast)

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Bill Perkins is one of the world's most successful hedge fund mana...

25 Nov 20241h 43min

#326 - AMA #65: Red light therapy: promising applications, mixed evidence, and impact on health and aging

#326 - AMA #65: Red light therapy: promising applications, mixed evidence, and impact on health and aging

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter dives into the worl...

18 Nov 202415min

#325 ‒ Peter's key takeaways on bone health, calorie restriction and energy balance, dopamine and addiction, gene editing, and testosterone therapy safety with a prostate cancer diagnosis | Quarterly Podcast Summary #3

#325 ‒ Peter's key takeaways on bone health, calorie restriction and energy balance, dopamine and addiction, gene editing, and testosterone therapy safety with a prostate cancer diagnosis | Quarterly Podcast Summary #3

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this quarterly podcast summary (QPS) episode, Peter summarizes ...

11 Nov 202425min

#324 ‒ Metabolism, energy balance, and aging: How diet, calorie restriction, and macronutrients influence longevity and metabolic health | Eric Ravussin, Ph.D.

#324 ‒ Metabolism, energy balance, and aging: How diet, calorie restriction, and macronutrients influence longevity and metabolic health | Eric Ravussin, Ph.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Eric Ravussin is a world-renowned expert on obesity, metabolism, a...

4 Nov 20242h 9min

#323 - CRISPR and the future of gene editing: scientific advances, genetic therapies, disease treatment potential, and ethical considerations | Feng Zhang, Ph.D.

#323 - CRISPR and the future of gene editing: scientific advances, genetic therapies, disease treatment potential, and ethical considerations | Feng Zhang, Ph.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Feng Zhang, a professor of neuroscience at MIT and a pioneering fi...

28 Okt 20242h 5min

#322 - Bone health for life: building strong bones, preventing age-related loss, and reversing osteoporosis with evidence-based exercise | Belinda Beck, Ph.D.

#322 - Bone health for life: building strong bones, preventing age-related loss, and reversing osteoporosis with evidence-based exercise | Belinda Beck, Ph.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Belinda Beck, founder of The Bone Clinic and a leading authority o...

21 Okt 20241h 39min

#321 – Dopamine and addiction: navigating pleasure, pain, and the path to recovery | Anna Lembke, M.D.

#321 – Dopamine and addiction: navigating pleasure, pain, and the path to recovery | Anna Lembke, M.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Anna Lembke is the Chief of the Stanford Addiction Medicine Dual D...

14 Okt 20242h 21min

#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape

#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter dives back into the...

7 Okt 202420min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
rss-jossan-nina
inga-beiga-morsor
alska-oss
rss-vuxna-pa-latsas
not-fanny-anymore
johannes-hansen-podcast
angestpodden
sexnoveller-deluxe
rss-viktmedicinpodden
sa-in-i-sjalen
brottarbroder
sova-med-dan-horning
rss-psykoterapipodden
rss-the-house-podcast-3
rss-sjalsligt-avkladd
rss-basta-livet
sex-pa-riktigt-med-marika-smith
tyngre-traningssnack